ENDRA Life Sciences Inc. (NDRA)

Market Cap	2.79M
Revenue (ttm)	n/a
Net Income (ttm)	-10.06M
Shares Out	11.04M
EPS (ttm)	-1.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,052
Open	0.252
Previous Close	0.242
Day's Range	0.242 - 0.257
52-Week Range	0.221 - 2.790
Beta	1.00
Analysts	n/a
Price Target	n/a
Earnings Date	May 13, 2024

About NDRA

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that al...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 9, 2017
• Employees: 21
• Stock Exchange: NASDAQ
• Ticker Symbol: NDRA